Date updated:05-17-2007
Okay, so I got hit bad by Dendreon, but who didn't? It was worth it to take a chance, especially after the surprisingly positive AC recommendation. But hindsight is 20/20, and I was blinded by message board contributors who didn't see the writing on the wall that pointed towards an approvable letter. But all is not lost if you are a true DNDN long as I still believe that the therapy has potential, and the experience has opened me up to the emerging cancer field, which even has it's own index fund in HHJ. This portfolio keeps track of all the stocks in this field, hopefully separating the wheat from the chaff.

-
ADLR
Adolor Corporatio - $1.51
- +0.67%
- $1.52
No Analysis added

-
AEZS
Aeterna Zentaris - $0.99
- +0.77%
- $0.9996
Adam Feuerstein answers questions about Genitope, Immunogen, and Nymox in his Biotech-Stock mailbag (http://www.thestreet.com/_tscs/newsanalysis/biotech/10354735.html). This is the only reason I added these stocks to this portfolio. Mainly to track to see if he is right. A reader asked if Genitope is the next Dendreon. Feuerstein thinks not, but sees competition with Genetech's non-Hodgkin's lymphoma drug. He doesn't see much hope for Immunogen either. And he doesn't like Nymox, instead recommending Spectrum and Aeterna Zentaris. So these stocks go into the Favorite column, and the others into Least Favorite. We'll see where they are in 6 months.

-
AGEN
Antigenics Inc. - $0.90
- -6.24%
- $0.9101
No Analysis added

-
ARRY
Array Biopharma I - $2.03
- +2.01%
- $2.01
No Analysis added

-
BDSI
Biodelivery Scien - $4.12
- -0.96%
- $4.16
No Analysis added

-
BUF
N/a - $0.19
- 0.00
- $0.19
No Analysis added

-
CEGE
- $0.00
- 0.00%
- $N/A
Mentioned on the yahoo message boards. People noticed how it tracked DNDN back when that stock was running. Need more info, though.

-
CYTR
Cytrx Corporation - $1.14
- +25.27%
- $0.98
No Analysis added
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the biggest stocks that made the 52-week high list on Nov. 20, 2009. more
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 20, 2009. more
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more













Comments not available